AAAAAA

   
Results: 1-23 |
Results: 23
THE INFLUENCE OF HLA-MATCHED SIBLING DONOR AVAILABILITY ON TREATMENT OUTCOME FOR PATIENTS WITH AML - AN ANALYSIS OF THE AML 8A STUDY OF THEEORTC-LEUKEMIA-COOPERATIVE-GROUP AND GIMEMA
Authors: KEATING S DEWITTE T SUCIU S WILLEMZE R HAYAT M LABAR B RESEGOTTI L FERRINI PR CARONIA F DARDENNE M SOLBU G PETTI MC VEGNA ML MANDELLI F ZITTOUN RA
Citation: S. Keating et al., THE INFLUENCE OF HLA-MATCHED SIBLING DONOR AVAILABILITY ON TREATMENT OUTCOME FOR PATIENTS WITH AML - AN ANALYSIS OF THE AML 8A STUDY OF THEEORTC-LEUKEMIA-COOPERATIVE-GROUP AND GIMEMA, British Journal of Haematology, 102(5), 1998, pp. 1344-1353
IMMUNOPHENOTYPE OF ADULT AND CHILDHOOD ACUTE PROMYELOCYTIC LEUKEMIA -CORRELATION WITH MORPHOLOGY, TYPE OF PML GENE BREAKPOINT AND CLINICALOUTCOME - A COOPERATIVE ITALIAN STUDY ON 196 CASES
Authors: GUGLIELMI C MARTELLI MP DIVERIO D FENU S VEGNA ML CANTURAJNOLDI A BIONDI A COCITO MG DELVECCHIO L TABILIO A AVVISATI G BASSO G LOCOCO F
Citation: C. Guglielmi et al., IMMUNOPHENOTYPE OF ADULT AND CHILDHOOD ACUTE PROMYELOCYTIC LEUKEMIA -CORRELATION WITH MORPHOLOGY, TYPE OF PML GENE BREAKPOINT AND CLINICALOUTCOME - A COOPERATIVE ITALIAN STUDY ON 196 CASES, British Journal of Haematology, 102(4), 1998, pp. 1035-1041
CLINICAL AND BIOLOGICAL RELEVANCE OF IMMUNOPHENOTYPE IN ACUTE PROMYELOCYTIC LEUKEMIA - A STUDY OF 196 CASES
Authors: GUGLIELMI C MARTELLI MP DIVERIO D FENU S VEGNA ML CANTURAJINOLDI A BIONDI R COCITO MG DELVECCHIO L TABILIO A AVVISATI G BASSO G LOCOCCO F
Citation: C. Guglielmi et al., CLINICAL AND BIOLOGICAL RELEVANCE OF IMMUNOPHENOTYPE IN ACUTE PROMYELOCYTIC LEUKEMIA - A STUDY OF 196 CASES, British Journal of Haematology, 102(1), 1998, pp. 14-15
CLINICAL RELEVANCE OF BCR ABL AND ALL1/AF4 MOLECULAR MARKERS IN ADULTACUTE LYMPHOBLASTIC-LEUKEMIA (ALL) - A RETROSPECTIVE STUDY/
Authors: ANNINO L ELIA L LAMANDA M FERRARI A VEGNA ML RAPANOTTI MC BUFFOLINO S LOCOCO F CIMINO G MANDELLI F
Citation: L. Annino et al., CLINICAL RELEVANCE OF BCR ABL AND ALL1/AF4 MOLECULAR MARKERS IN ADULTACUTE LYMPHOBLASTIC-LEUKEMIA (ALL) - A RETROSPECTIVE STUDY/, British Journal of Haematology, 102(1), 1998, pp. 227-227
SECONDARY HEMATOLOGICAL NEOPLASM AFTER TREATMENT OF ADULT ACUTE LYMPHOBLASTIC-LEUKEMIA - ANALYSIS OF 1170 ADULT ALL PATIENTS ENROLLED IN THE GIMEMA TRIALS
Authors: PAGANO L ANNINO L FERRARI A CAMERA A MARTINO B MONTILLO M TOSTI ME MELE A PULSONI A VEGNA ML LEONE G MANDELLI F
Citation: L. Pagano et al., SECONDARY HEMATOLOGICAL NEOPLASM AFTER TREATMENT OF ADULT ACUTE LYMPHOBLASTIC-LEUKEMIA - ANALYSIS OF 1170 ADULT ALL PATIENTS ENROLLED IN THE GIMEMA TRIALS, British Journal of Haematology, 100(4), 1998, pp. 669-676
P53 EXPRESSION IN B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA - A MARKER OF DISEASE PROGRESSION AND POOR-PROGNOSIS
Authors: CORDONE I MASI S MAURO FR SODDU S MORSILLI O VALENTINI T VEGNA ML GUGLIELMI C MANCINI F GIULIACCI S SACCHI A MANDELLI F FOA R
Citation: I. Cordone et al., P53 EXPRESSION IN B-CELL CHRONIC LYMPHOCYTIC-LEUKEMIA - A MARKER OF DISEASE PROGRESSION AND POOR-PROGNOSIS, Blood, 91(11), 1998, pp. 4342-4349
IMMUNOPHENOTYPE OF ADULT AND CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA -CHANGES AT FIRST RELAPSE AND CLINICOPROGNOSTIC IMPLICATIONS
Authors: GUGLIELMI C CORDONE I BOECKLIN F MASI S VALENTINI T VEGNA ML FERRARI A TESTI AM FOA R
Citation: C. Guglielmi et al., IMMUNOPHENOTYPE OF ADULT AND CHILDHOOD ACUTE LYMPHOBLASTIC-LEUKEMIA -CHANGES AT FIRST RELAPSE AND CLINICOPROGNOSTIC IMPLICATIONS, Leukemia, 11(9), 1997, pp. 1501-1507
MOLECULAR REMISSION IN PML RAR-ALPHA-POSITIVE ACUTE PROMYELOCYTIC LEUKEMIA BY COMBINED ALL-TRANS-RETINOIC ACID AND IDARUBICIN (AIDA) THERAPY/
Authors: MANDELLI F DIVERIO D AVVISATI G LUCIANO A BARBUI T BERNASCONI C BROCCIA G CERRI R FALDA M FIORITONI G LEONI F LISO V PETTI MC RODEGHIERO F SAGLIO G VEGNA ML VISANI G JEHN U WILLEMZE R MUUS P PELICCI PG BIONDI A LOCOCO F
Citation: F. Mandelli et al., MOLECULAR REMISSION IN PML RAR-ALPHA-POSITIVE ACUTE PROMYELOCYTIC LEUKEMIA BY COMBINED ALL-TRANS-RETINOIC ACID AND IDARUBICIN (AIDA) THERAPY/, Blood, 90(3), 1997, pp. 1014-1021
IMMUNOPHENOTYPE OF ADULT AND CHILDHOOD ACUTE PROMYELOCYTIC LEUKEMIA -CORRELATION WITH MORPHOLOGY AND TYPE OF PML GENE BREAKPOINT - A COOPERATIVE ITALIAN STUDY ON 196 CASES
Authors: GUGLIELMI C MARTELLI MP DIVERIO D FENU S VEGNA ML CANTURAJNOLDI A BIONDI A COCITO MG DELVECCHIO L TABILIO A BASSO G LOCOCO F
Citation: C. Guglielmi et al., IMMUNOPHENOTYPE OF ADULT AND CHILDHOOD ACUTE PROMYELOCYTIC LEUKEMIA -CORRELATION WITH MORPHOLOGY AND TYPE OF PML GENE BREAKPOINT - A COOPERATIVE ITALIAN STUDY ON 196 CASES, Blood, 90(10), 1997, pp. 3694-3694
MULTIDRUG-RESISTANCE (MDR1) IN YOUNGER ADULT DE-NOVO ACUTE MYELOID-LEUKEMIA PATIENTS - LOW-FREQUENCY OF EXPRESSION AND LARK OF UNFAVORABLE PROGNOSTIC VALUE
Authors: ARIOLA C PETRUCCI MT RICCIARDI MR GREGORJ C BRECCIA M DECUIA R VEGNA ML PETTI MC TAFURI A
Citation: C. Ariola et al., MULTIDRUG-RESISTANCE (MDR1) IN YOUNGER ADULT DE-NOVO ACUTE MYELOID-LEUKEMIA PATIENTS - LOW-FREQUENCY OF EXPRESSION AND LARK OF UNFAVORABLE PROGNOSTIC VALUE, Blood, 90(10), 1997, pp. 798-798
HEMOSTASIS RELATED EARLY MORBIDITY AND MORTALITY DURING REMISSION INDUCTION TREATMENT WITH OR WITHOUT ALL-TRANS-RETINOIC ACID (ATRA) IN ACUTE PROMYELOCYTIC LEUKEMIA (APL)
Authors: DIBONA E CASTAMAN G AVVISATI G GUGLIOTTA L VEGNA ML RODEGHIERO F MANDELLI F
Citation: E. Dibona et al., HEMOSTASIS RELATED EARLY MORBIDITY AND MORTALITY DURING REMISSION INDUCTION TREATMENT WITH OR WITHOUT ALL-TRANS-RETINOIC ACID (ATRA) IN ACUTE PROMYELOCYTIC LEUKEMIA (APL), Blood, 90(10), 1997, pp. 1478-1478
PROSPECTIVE RT-PCR MONITORING OF MINIMAL RESIDUAL DISEASE IN ACUTE PROMYELOCYTIC LEUKEMIA (APL) PATIENTS ENROLLED IN THE MULTICENTRIC GIMEMA-AIEOP AIDA TRIAL
Authors: LOCOCO F DIVERIO D AVVISATI G LUCIANO A DESANTIS S SANTORO A PANE F MARTINELLI G PELICCI PG VEGNA ML SAGLIO G BIONDI A MANDELLI F
Citation: F. Lococo et al., PROSPECTIVE RT-PCR MONITORING OF MINIMAL RESIDUAL DISEASE IN ACUTE PROMYELOCYTIC LEUKEMIA (APL) PATIENTS ENROLLED IN THE MULTICENTRIC GIMEMA-AIEOP AIDA TRIAL, Blood, 90(10), 1997, pp. 1734-1734
MULTIMODALITY TREATMENT OF THYMOMA - A PROSPECTIVE-STUDY
Authors: VENUTA F RENDINA EA PESCARMONA EO DEGIACOMO T VEGNA ML FAZI P FLAISHMAN I GUARINO E RICCI C
Citation: F. Venuta et al., MULTIMODALITY TREATMENT OF THYMOMA - A PROSPECTIVE-STUDY, The Annals of thoracic surgery, 64(6), 1997, pp. 1585-1591
PROGNOSTIC FACTORS OF PATIENTS WITH ACUTE MYELOID-LEUKEMIA (AML) ALLOGRAFTED IN FIRST COMPLETE REMISSION - AN ANALYSIS OF THE EORTC-GIMEMA AML 8A TRIAL
Authors: KEATING S SUCIU S DEWITTE T MANDELLI F WILLEMZE R RESEGOTTI L BROCCIA G THALER J LABAR B DAMASIO E BIZZI B ROTOLI B VEKHOFF A MUUS P PETTI MC DARDENNE M SOLBU G VEGNA ML ZITTOUN R
Citation: S. Keating et al., PROGNOSTIC FACTORS OF PATIENTS WITH ACUTE MYELOID-LEUKEMIA (AML) ALLOGRAFTED IN FIRST COMPLETE REMISSION - AN ANALYSIS OF THE EORTC-GIMEMA AML 8A TRIAL, Bone marrow transplantation, 17(6), 1996, pp. 993-1001
RISK-FACTORS FOR ESSENTIAL THROMBOCYTHEMIA - A CASE-CONTROL STUDY
Authors: MELE A VISANI G PULSONI A MONARCA B CASTELLI G STAZI MA GENTILE G MANDELLI F RASCHETTI R IANTOSCA G DACAS R FERRIGNO L VITALE A VEGNA ML MARTINO P MERANTE S BERNASCONI CB LIVRAGHI A BONI M COLOMBINI R GUGLIOTTA L TURA S
Citation: A. Mele et al., RISK-FACTORS FOR ESSENTIAL THROMBOCYTHEMIA - A CASE-CONTROL STUDY, Cancer, 77(10), 1996, pp. 2157-2161
G-CSF INDUCES MOBILIZATION ON BOTH CD34 POSITIVE AND PROLIFERATING CD34 NEGATIVE CELLS IN HEALTHY DONORS
Authors: FULVI A FALZETTI F VEGNA ML GIANNONI C CARINI V MARTELLI MF TABILIO A
Citation: A. Fulvi et al., G-CSF INDUCES MOBILIZATION ON BOTH CD34 POSITIVE AND PROLIFERATING CD34 NEGATIVE CELLS IN HEALTHY DONORS, Blood, 88(10), 1996, pp. 1581-1581
IMMUNOPHENOTYPE OF THE EORTC GIMEMA AML-10 PROTOCOL - CLINICAL RELEVANCE AND CYTOGENETIC CORRELATION/
Authors: BERNIER M SUCIU S STRYCKMANS P DEWITTE T DARDENNE M SOLBU G VEGNA ML WILLEMZE R MANDELLI F ZITTOUN R
Citation: M. Bernier et al., IMMUNOPHENOTYPE OF THE EORTC GIMEMA AML-10 PROTOCOL - CLINICAL RELEVANCE AND CYTOGENETIC CORRELATION/, Blood, 88(10), 1996, pp. 2232-2232
AUTOLOGOUS OR ALLOGENEIC BONE-MARROW TRANSPLANTATION COMPARED WITH INTENSIVE CHEMOTHERAPY IN ACUTE MYELOGENOUS LEUKEMIA
Authors: ZITTOUN RA MANDELLI F WILLEMZE R DEWITTE T LABAR B RESEGOTTI L LEONI F DAMASIO E VISANI G PAPA G CARONIA F HAYAT M STRYCKMANS P ROTOLI B LEONI P PEETERMANS ME DARDENNE M VEGNA ML PETTI MC SOLBU G SUCIU S
Citation: Ra. Zittoun et al., AUTOLOGOUS OR ALLOGENEIC BONE-MARROW TRANSPLANTATION COMPARED WITH INTENSIVE CHEMOTHERAPY IN ACUTE MYELOGENOUS LEUKEMIA, The New England journal of medicine, 332(4), 1995, pp. 217-223
EORTC-GIMEMA AML8 PROTOCOL - A PHASE-III STUDY ON AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN ACUTE MYELOGENOUS LEUKEMIA (AML)
Authors: ZITTOUN R MANDELLI E WILLEMZE R DEWITTE T LABAR B RESEGOTTI L FERRINI R VISANI G CARONIA E STRYCKMANS P MARMONT A HAYAT M UMLAUFT F ROTOLI B PEETERMANS M PAPA LP PETTI MC DARDENNE M SOLBU G VEGNA ML SUCIU S
Citation: R. Zittoun et al., EORTC-GIMEMA AML8 PROTOCOL - A PHASE-III STUDY ON AUTOLOGOUS BONE-MARROW TRANSPLANTATION IN ACUTE MYELOGENOUS LEUKEMIA (AML), Leukemia & lymphoma, 13, 1994, pp. 101-101
AUTOLOGOUS BMT IN 199 AML PATIENTS IN CR - 10-YEAR EXPERIENCE AT THE HEMATOLOGY OF THE UNIVERSITY-LA-SAPIENZA OF ROME, ITALY
Authors: MELONI G VIGNETTI M AVVISATI G ANDRIZZI C CAPRIA S ORSINI E SIMONE F TODISCO E VEGNA ML MANDELLI F
Citation: G. Meloni et al., AUTOLOGOUS BMT IN 199 AML PATIENTS IN CR - 10-YEAR EXPERIENCE AT THE HEMATOLOGY OF THE UNIVERSITY-LA-SAPIENZA OF ROME, ITALY, Blood, 84(10), 1994, pp. 10000202-10000202
REPRODUCIBILITY OF THE MORPHOLOGICAL DIAGNOSTIC-CRITERIA FOR ACUTE MYELOID-LEUKEMIA - THE GIMEMA GROUP EXPERIENCE
Authors: CASTOLDI GL LISO V FENU S VEGNA ML MANDELLI F
Citation: Gl. Castoldi et al., REPRODUCIBILITY OF THE MORPHOLOGICAL DIAGNOSTIC-CRITERIA FOR ACUTE MYELOID-LEUKEMIA - THE GIMEMA GROUP EXPERIENCE, Annals of hematology, 66(4), 1993, pp. 171-174
MITOXANTRONE, ETOPOSIDE AND INTERMEDIATE-DOSE ARA-C (MEC) - AN EFFECTIVE REGIMEN FOR POOR RISK ACUTE MYELOID-LEUKEMIA
Authors: SPADEA A PETTI MC FAZI P VEGNA ML ARCESE W AVVISATI G SPIRITI MAA LATAGLIATA R MELONI G TESTI AM AMADORI S MANDELLI F
Citation: A. Spadea et al., MITOXANTRONE, ETOPOSIDE AND INTERMEDIATE-DOSE ARA-C (MEC) - AN EFFECTIVE REGIMEN FOR POOR RISK ACUTE MYELOID-LEUKEMIA, Leukemia, 7(4), 1993, pp. 549-552
PROSPECTIVE PHASE-III STUDY OF AUTOLOGOUS BONE-MARROW TRANSPLANTATION(ABMT) NU SHORT INTENSIVE CHEMOTHERAPY (IC) V ALLOGENEIC BONE-MARROW TRANSPLANTATION (ALLO-BMT) DURING 1ST COMPLETE REMISSION (CR) OF ACUTEMYELOGENOUS LEUKEMIA (AML) - RESULTS OF THE EORTC-GIMEMA AML-8A TRIAL
Authors: ZITTOUN R MANDELLI F WILLEMZE R DEWITTE T LABAR B RESEGOTTI L FERRINI PR VISANI G CARONIA F STRYCKMANS P MARMONT A HAYAT M UMLAUFT F ROTOLI B PEETERMANS M PAPA G LEONI P PETTI MC DARDENNE M SOLBU G VEGNA ML SUCIU S
Citation: R. Zittoun et al., PROSPECTIVE PHASE-III STUDY OF AUTOLOGOUS BONE-MARROW TRANSPLANTATION(ABMT) NU SHORT INTENSIVE CHEMOTHERAPY (IC) V ALLOGENEIC BONE-MARROW TRANSPLANTATION (ALLO-BMT) DURING 1ST COMPLETE REMISSION (CR) OF ACUTEMYELOGENOUS LEUKEMIA (AML) - RESULTS OF THE EORTC-GIMEMA AML-8A TRIAL, Blood, 82(10), 1993, pp. 10000085-10000085
Risultati: 1-23 |